234 related articles for article (PubMed ID: 9611224)
1. Cisplatin inhibits synthesis of ribosomal RNA in vivo.
Jordan P; Carmo-Fonseca M
Nucleic Acids Res; 1998 Jun; 26(12):2831-6. PubMed ID: 9611224
[TBL] [Abstract][Full Text] [Related]
2. In vivo evidence that TATA-binding protein/SL1 colocalizes with UBF and RNA polymerase I when rRNA synthesis is either active or inactive.
Jordan P; Mannervik M; Tora L; Carmo-Fonseca M
J Cell Biol; 1996 Apr; 133(2):225-34. PubMed ID: 8609157
[TBL] [Abstract][Full Text] [Related]
3. Coactivator and promoter-selective properties of RNA polymerase I TAFs.
Beckmann H; Chen JL; O'Brien T; Tjian R
Science; 1995 Dec; 270(5241):1506-9. PubMed ID: 7491500
[TBL] [Abstract][Full Text] [Related]
4. Recruitment of TATA-binding protein-TAFI complex SL1 to the human ribosomal DNA promoter is mediated by the carboxy-terminal activation domain of upstream binding factor (UBF) and is regulated by UBF phosphorylation.
Tuan JC; Zhai W; Comai L
Mol Cell Biol; 1999 Apr; 19(4):2872-9. PubMed ID: 10082553
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factor.
Zhai X; Beckmann H; Jantzen HM; Essigmann JM
Biochemistry; 1998 Nov; 37(46):16307-15. PubMed ID: 9819223
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor).
Treiber DK; Zhai X; Jantzen HM; Essigmann JM
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5672-6. PubMed ID: 8202546
[TBL] [Abstract][Full Text] [Related]
7. Nucleolar protein upstream binding factor is sequestered into adenovirus DNA replication centres during infection without affecting RNA polymerase I location or ablating rRNA synthesis.
Lawrence FJ; McStay B; Matthews DA
J Cell Sci; 2006 Jun; 119(Pt 12):2621-31. PubMed ID: 16763197
[TBL] [Abstract][Full Text] [Related]
8. Initiation of nucleolar assembly is independent of RNA polymerase I transcription.
Dousset T; Wang C; Verheggen C; Chen D; Hernandez-Verdun D; Huang S
Mol Biol Cell; 2000 Aug; 11(8):2705-17. PubMed ID: 10930464
[TBL] [Abstract][Full Text] [Related]
9. The RNA polymerase I transcription factor, upstream binding factor, interacts directly with the TATA box-binding protein.
Kwon H; Green MR
J Biol Chem; 1994 Dec; 269(48):30140-6. PubMed ID: 7982918
[TBL] [Abstract][Full Text] [Related]
10. Depletion of the cisplatin targeted HMGB-box factor UBF selectively induces p53-independent apoptotic death in transformed cells.
Hamdane N; Herdman C; Mars JC; Stefanovsky V; Tremblay MG; Moss T
Oncotarget; 2015 Sep; 6(29):27519-36. PubMed ID: 26317157
[TBL] [Abstract][Full Text] [Related]
11. SV40 large T antigen binds to the TBP-TAF(I) complex SL1 and coactivates ribosomal RNA transcription.
Zhai W; Tuan JA; Comai L
Genes Dev; 1997 Jun; 11(12):1605-17. PubMed ID: 9203586
[TBL] [Abstract][Full Text] [Related]
12. Assembly of transcriptionally active RNA polymerase I initiation factor SL1 from recombinant subunits.
Zomerdijk JC; Beckmann H; Comai L; Tjian R
Science; 1994 Dec; 266(5193):2015-8. PubMed ID: 7801130
[TBL] [Abstract][Full Text] [Related]
13. The cell cycle regulatory factor TAF1 stimulates ribosomal DNA transcription by binding to the activator UBF.
Lin CY; Tuan J; Scalia P; Bui T; Comai L
Curr Biol; 2002 Dec; 12(24):2142-6. PubMed ID: 12498690
[TBL] [Abstract][Full Text] [Related]
14. Involvement of phosphatidylinositol 4,5-bisphosphate in RNA polymerase I transcription.
Yildirim S; Castano E; Sobol M; Philimonenko VV; Dzijak R; Venit T; Hozák P
J Cell Sci; 2013 Jun; 126(Pt 12):2730-9. PubMed ID: 23591814
[TBL] [Abstract][Full Text] [Related]
15. Mouse rRNA gene transcription factor mUBF requires both HMG-box1 and an acidic tail for nucleolar accumulation: molecular analysis of the nucleolar targeting mechanism.
Maeda Y; Hisatake K; Kondo T; Hanada K; Song CZ; Nishimura T; Muramatsu M
EMBO J; 1992 Oct; 11(10):3695-704. PubMed ID: 1396565
[TBL] [Abstract][Full Text] [Related]
16. HMG box 4 is the principal determinant of species specificity in the RNA polymerase I transcription factor UBF.
Cairns C; McStay B
Nucleic Acids Res; 1995 Nov; 23(22):4583-90. PubMed ID: 8524646
[TBL] [Abstract][Full Text] [Related]
17. Mitotic silencing of human rRNA synthesis: inactivation of the promoter selectivity factor SL1 by cdc2/cyclin B-mediated phosphorylation.
Heix J; Vente A; Voit R; Budde A; Michaelidis TM; Grummt I
EMBO J; 1998 Dec; 17(24):7373-81. PubMed ID: 9857193
[TBL] [Abstract][Full Text] [Related]
18. The RNA polymerase I-specific transcription initiation factor UBF is associated with transcriptionally active and inactive ribosomal genes.
Zatsepina OV; Voit R; Grummt I; Spring H; Semenov MV; Trendelenburg MF
Chromosoma; 1993 Nov; 102(9):599-611. PubMed ID: 8306821
[TBL] [Abstract][Full Text] [Related]
19. DNA looping in the RNA polymerase I enhancesome is the result of non-cooperative in-phase bending by two UBF molecules.
Stefanovsky VY; Pelletier G; Bazett-Jones DP; Crane-Robinson C; Moss T
Nucleic Acids Res; 2001 Aug; 29(15):3241-7. PubMed ID: 11470882
[TBL] [Abstract][Full Text] [Related]
20. Involvement of in situ conformation of ribosomal genes and selective distribution of upstream binding factor in rRNA transcription.
Junéra HR; Masson C; Géraud G; Suja J; Hernandez-Verdun D
Mol Biol Cell; 1997 Jan; 8(1):145-56. PubMed ID: 9017602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
